Increase/Decrease in Cash: The total change in cash for the company over the given period.
China SXT Pharmaceuticals, Inc. (SXTC) had Increase/Decrease in Cash of $6.05M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$21.30M |
|
$2.60M |
|
$2.61M |
|
$21.66M |
|
$6.01M |
|
$0.10M |
|
$0.10M |
|
$6.22M |
|
$15.44M |
|
$15.43M |
|
$15.44M |
|
-- |
|
| Cash Flow Statement Financials | |
$-2.35M |
|
$0.06M |
|
$8.40M |
|
$12.08M |
|
$18.13M |
|
|
Increase/Decrease in Cash |
$6.05M |
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|